| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |